文献速递癫痫认知障碍与痴呆

因神经元迁移及迁移后发育异常所致皮质畸形伴癫痫的长期结局:一项队列研究

Long-term Outcome of Epilepsy and Cortical Malformations Due to Abnormal Migration and Postmigrational Development: A Cohort Study.
PubMed 文献 · Neurology · 2022-04-11

该历史性队列研究纳入71例因神经元迁移及迁移后组织异常所致皮质畸形(MCD)的癫痫患者,中位随访17年。从纳入起20年累积缓解率为38%。Cox模型显示MCD单侧分布(HR 2.68,95%CI 1.04-6.92)和起病时低发作频率(HR 5.01,95%CI 1.12-22.5)与缓解显著相关。

要点

  • MCD单侧分布与缓解相关(HR 2.68,95%CI 1.04-6.92)。
  • 起病时低发作频率与缓解相关(HR 5.01,95%CI 1.12-22.5)。
  • 从纳入起20年累积缓解率为38%。

核心结论

  • 癫痫伴MCD患者从起病起20年缓解率为38%。
  • MCD单侧分布与约3倍的缓解概率相关。
  • 约40%患者表现为药物敏感状态,但病程中有复发风险。

研究设计与样本

  • 历史性队列研究,纳入71例(男31/女40)因神经元迁移及迁移后组织异常所致MCD的癫痫患者,随访≥5年,中位随访17年(1506人年)。
  • 由专家神经放射科医生重新准确评估神经影像后对MCD进行分类。
  • 主要结局为缓解,定义为从癫痫起病起任何时间达到≥5年无发作。
  • 采用Kaplan-Meier估计进行生存分析,采用单因素和多因素Cox回归分析评估基线变量与缓解的可能关联。

主要发现

  • 49.3%患者为灰质异位,35.2%为多小脑回,7%为无脑回,8.5%为2种MCD组合。
  • 癫痫起病平均年龄为12.4±7.2岁。
  • 智力障碍和神经功能缺损分别见于30.4%和40.9%的患者。
  • 超过60%患者为难治性癫痫。
  • 3例接受癫痫手术的患者经组织学确认MCD诊断。

关键数值与推荐

  • 缓解定义为从癫痫起病起任何时间达到≥5年无发作。
  • MCD单侧分布与缓解相关(HR 2.68,95%CI 1.04-6.92)。
  • 起病时低发作频率与缓解相关(HR 5.01,95%CI 1.12-22.5)。

临床怎么用

  • 本研究提供II级证据:癫痫伴MCD患者中,MCD单侧分布和起病时低发作频率与达到癫痫缓解相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the long-term outcomes of patients with epilepsy and malformations of cortical development (MCD). METHODS: We conducted a historical cohort study of patients with epilepsy and MCD due to impaired neuronal migration and postmigration organization with a follow-up period of ≥5 years. For each patient, MCD was classified after accurate neuroimaging reappraisal by an expert neuroradiologist. The primary outcome was remission, defined as a period of seizure freedom ≥5 years at any time from epilepsy onset. We used Kaplan-Meier estimates for survival analysis and univariate and multivariate Cox regression analyses to evaluate baseline variables as possible factors associated with remission. RESULTS: The cohort included 71 patients (M/F 31/40) with a 17-year median follow-up (1,506 person-years). About half (49.3%) had heterotopia, 35.2% polymicrogyria, 7% lissencephaly, and 8.5% the combination of 2 MCD. The mean age at seizure onset was 12.4 ± 7.2 years. Intellectual disability and neurologic deficits were observed in 30.4% and 40.9%, respectively. More than 60% of patients had refractory epilepsy. In 3 patients who underwent epilepsy surgery, MCD diagnosis was confirmed by histology. At the last visit, 44% of patients had been seizure-free during the previous year, but none of them had stopped antiseizure medication. Thirty patients achieved remission (42.2%) at some point in their disease history, whereas 41 individuals (57.8%) had never been in remission for ≥5 years. The cumulative remission rate was 38% by 20 years from inclusion. In the Cox model, unilateral distribution of MCD (hazard ratio [HR] 2.68, 95% CI 1.04-6.92) and a low seizure frequency at onset (HR 5.01, 95% CI 1.12-22.5) were significantly associated with remission. DISCUSSION: Patients with epilepsy and MCD showed a remission rate of 38% by 20 years from onset. Unilateral distribution of the MCD is associated with a 3-fold probability of achieving remission. About 40% of patients showed a drug-sensitive condition with risk of relapse during their epilepsy course. CLASSIFICATION OF EVIDENCE: This study provides Class II evidence that in patients with epilepsy and MCD, unilateral MCD and low seizure frequency at onset are associated with achieving epilepsy remission.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Licchetta L, Vignatelli L, Toni F, et al. Long-term Outcome of Epilepsy and Cortical Malformations Due to Abnormal Migration and Postmigrational Development: A Cohort Study. Neurology. 2022. PMID: 35410907. doi:10.1212/WNL.0000000000200352

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。